Point-of-care molecular diagnostics represent 52.7% of product type sales in 2026. The point-of-care molecular diagnostics market is estimated at USD 5.8 billion in 2026, is projected to reach USD 15.1 billion by 2036 and is forecast to post a 10.0% CAGR between 2026 and 2036.